What question did this study set out to answer?

This research aims to determine if oleacein can prevent metabolic dysfunction-related fatty liver disease and dyslipidaemia in mice lacking the ApoE gene.

May 10, 2026Open Access

Oleacein prevents metabolic dysfunction–associated hepatic steatosis and dyslipidaemia in ApoE-KO mice

Puntos clave

This research aims to determine if oleacein can prevent metabolic dysfunction-related fatty liver disease and dyslipidaemia in mice lacking the ApoE gene.
Utilized ApoE-KO mice to investigate oleacein's effects on metabolic factors.
Evaluated cardiometabolic risk factors related to hepatic steatosis and dyslipidaemia.
Oleacein significantly reduced markers of hepatic steatosis in treatment group versus control peer group.
Dyslipidaemia was effectively lowered with oleacein, suggesting improved lipid profiles.

Resumen

The modification of cardiometabolic risk factors is a major strategy to prevent metabolic dysfunction–associated fatty liver disease (MAFLD), given the current lack of approved pharmacological treatments. This study investigated whether...

Me gusta

Guardar

Ver artículo completo

Cite This Study

Ormonde et al. (Thu,) studied this question.

synapsesocial.com/papers/6a0020cec8f74e3340f9bb0f https://doi.org/https://doi.org/10.1039/d5fo05134g

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Me gusta

Guardar

Ver artículo completo